Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,421 public trials 1,034 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

NCT01363817

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • The University Of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Local Institution Marseille, France
View Trial Details
Completed

Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib

NCT02348957

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • Praxis für Hämatologie und internistische Onkologie Heidenheim, Baden-Wurttemberg, Germany
  • Ambulantes Therapiezentrum Offenburg, Baden-Wurttemberg, Germany
  • Diakonie-Klinikum Schwäbisch Hall GmbH, Klinik für Innere Medizin III Schwäbisch Hall, Baden-Wurttemberg, Germany
  • Praxisklinik für integrative Onkologie Altötting, Bavaria, Germany
View all 66 locations
View Trial Details
Completed

Clinical Study of WT2725 in Patients With Advanced Malignancies

NCT01621542

Conditions
Cancer, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +20 more
Locations
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
View Trial Details
Completed

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas

NCT01282424

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations
  • St. Jude Medical Center Fullerton, California, United States
  • Pacific Shores Medical Group Long Beach, California, United States
  • UCLA Los Angeles, California, United States
  • Central Coast Medical Oncology Santa Maria, California, United States
View all 41 locations
View Trial Details

Related conditions